Michael M. Goldberg, M.D.,

Navidea President and Chief Executive Officer

Michael Goldberg

Michael M. Goldberg, M.D. was appointed Navidea’s President and Chief Executive Officer in September 2016.  He has been a member of the Navidea Board of Directors since November 2013, serving as Chairman of the Board from March to September 2016 and as interim Chief Executive Officer from May to October 2014.  Dr. Goldberg has been a Managing Partner of Montaur Capital Partners since January 2007.  Prior to this, he served as the Chief Executive Officer of Emisphere Technologies, Inc., from August 1990 to January 16, 2007, and as its President from August 1990 to October 1995.  He served as Vice President of The First Boston Corp., where he was a founding member of the Healthcare Banking Group.  Dr. Goldberg is or has been a Director of Alliqua, Inc., Echo Therapeutics, Inc., AngioLight, Inc., Urigen Pharmaceuticals, Inc., and Adventrx Pharmaceuticals, Inc.  Dr. Goldberg received a B.S. degree from Rensselaer Polytechnic Institute, an M.D. from Albany Medical College of Union University in 1982, and an M.B.A. from Columbia University Graduate School of Business in 1985.